VanEck Pharmaceutical ETF
PPH
PPH
46 hedge funds and large institutions have $121M invested in VanEck Pharmaceutical ETF in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
11
Closed
6
Calls
$361K
Puts
$24.3M
Net Calls
-$24M
Net Calls Change
-$23.7M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$31.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.83M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$1.59M |
| 4 |
IMC Chicago
Chicago,
Illinois
|
+$1.35M |
| 5 |
DI
DFPG Investments
Sandy,
Utah
|
+$703K |
Top Sellers
| 1 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
-$4.97M |
| 2 |
Goldman Sachs
New York
|
-$2.76M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.37M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$807K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
-$595K |
